Coffee, CYP1A2 genotype, and risk of myocardial infarction. Cornelis MC, El-Sohemy A, Kabagambe EK, Campos H (2006) JAMA 295: 1135-41 CYP1A1/2 haplotypes and lung cancer and assessment of confounding by population stratification. Aldrich MC, Selvin S, Hansen HM, Barcellos LF, Wrensch MR, Sison JD, Kelsey KT, Buffler PA, Quesenberry CP, Seldin MF, Wiencke JK (2009) Cancer Res 69: 2340-8 Inhibition of human cytochrome P450-catalyzed oxidations of xenobiotics and procarcinogens by synthetic organoselenium compounds. Shimada T, El-Bayoumy K, Upadhyaya P, Sutter TR, Guengerich FP, Yamazaki H (1997) Cancer Res 57: 4757-64 Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes. Guengerich FP, Shimada T, Yun CH, Yamazaki H, Raney KD, Thier R, Coles B, Harris TM (1994) Environ Health Perspect 102 Suppl 9: 49-53 Co-Prescription of Strong CYP1A2 Inhibitors and the Risk of Tizanidine-Associated Hypotension: A Retrospective Cohort Study. Chaugai S, Dickson AL, Shuey MM, Feng Q, Barker KA, Wei WQ, Luther JM, Stein CM, Chung CP (2019) Clin Pharmacol Ther 105: 703-709 The contribution of UDP-glucuronosyltransferase 1A9 on CYP1A2-mediated genotoxicity by aromatic and heterocyclic amines. Yueh MF, Nguyen N, Famourzadeh M, Strassburg CP, Oda Y, Guengerich FP, Tukey RH (2001) Carcinogenesis 22: 943-50 Discovery, Structure-Activity Relationship, and Biological Characterization of a Novel Series of 6-((1 H-Pyrazolo[4,3- b]pyridin-3-yl)amino)-benzo[ d]isothiazole-3-carboxamides as Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 4 (mGlu). Bollinger SR, Engers DW, Panarese JD, West M, Engers JL, Loch MT, Rodriguez AL, Blobaum AL, Jones CK, Thompson Gray A, Conn PJ, Lindsley CW, Niswender CM, Hopkins CR (2019) J Med Chem 62: 342-358 What makes P450s work? Searches for answers with known and new P450s. Guengerich FP, Parikh A, Yun CH, Kim D, Nakamura K, Notley LM, Gillam EM (2000) Drug Metab Rev 32: 267-81 Detection of free radicals produced from the reaction of cytochrome P-450 with linoleic acid hydroperoxide. Rota C, Barr DP, Martin MV, Guengerich FP, Tomasi A, Mason RP (1997) Biochem J 328 ( Pt 2): 565-71 Molecular cloning and expression of two novel avian cytochrome P450 1A enzymes induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Gilday D, Gannon M, Yutzey K, Bader D, Rifkind AB (1996) J Biol Chem 271: 33054-9 Diversity in mechanisms of substrate oxidation by cytochrome P450 2D6. Lack of an allosteric role of NADPH-cytochrome P450 reductase in catalytic regioselectivity. Hanna IH, Krauser JA, Cai H, Kim MS, Guengerich FP (2001) J Biol Chem 276: 39553-61 Cooperativity in oxidation reactions catalyzed by cytochrome P450 1A2: highly cooperative pyrene hydroxylation and multiphasic kinetics of ligand binding. Sohl CD, Isin EM, Eoff RL, Marsch GA, Stec DF, Guengerich FP (2008) J Biol Chem 283: 7293-308 Characterization of human lung microsomal cytochrome P-450 1A1 and its role in the oxidation of chemical carcinogens. Shimada T, Yun CH, Yamazaki H, Gautier JC, Beaune PH, Guengerich FP (1992) Mol Pharmacol 41: 856-64 Interspecies differences in metabolism of heterocyclic aromatic amines by rat and human P450 1A2. Turesky RJ, Constable A, Fay LB, Guengerich FP (1999) Cancer Lett 143: 109-12 Kinetic deuterium isotope effects for 7-alkoxycoumarin O-dealkylation reactions catalyzed by human cytochromes P450 and in liver microsomes. Rate-limiting C-H bond breaking in cytochrome P450 1A2 substrate oxidation. Kim KH, Isin EM, Yun CH, Kim DH, Guengerich FP (2006) FEBS J 273: 2223-31 Molecular modelling of CYP1 family enzymes CYP1A1, CYP1A2, CYP1A6 and CYP1B1 based on sequence homology with CYP102. Lewis DF, Lake BG, George SG, Dickins M, Eddershaw PJ, Tarbit MH, Beresford AP, Goldfarb PS, Guengerich FP (1999) Toxicology 139: 53-79 Bioactivation of diesel exhaust particle extracts and their major nitrated polycyclic aromatic hydrocarbon components, 1-nitropyrene and dinitropyrenes, by human cytochromes P450 1A1, 1A2, and 1B1. Yamazaki H, Hatanaka N, Kizu R, Hayakawa K, Shimada N, Guengerich FP, Nakajima M, Yokoi T (2000) Mutat Res 472: 129-38 Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP1A2 and NADPH-P450 reductase. Aryal P, Yoshikawa K, Terashita T, Guengerich FP, Shimada T, Oda Y (1999) Mutat Res 442: 113-20 Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype. Guengerich FP, Parikh A, Turesky RJ, Josephy PD (1999) Mutat Res 428: 115-24 Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2. Turesky RJ, Guengerich FP, Guillouzo A, Langouët S (2002) Mutat Res 506-507: 187-95 Plasmid-mediated expression of the UmuDC mutagenesis proteins in an Escherichia coli strain engineered for human cytochrome P450 1A2-catalyzed activation of aromatic amines. Josephy PD, Evans DH, Williamson V, Henry T, Guengerich FP (1999) Mutat Res 429: 199-208 Use of genetically engineered Salmonella typhimurium OY1002/1A2 strain coexpressing human cytochrome P450 1A2 and NADPH-cytochrome P450 reductase and bacterial O-acetyltransferase in SOS/umu assay. Aryal P, Terashita T, Guengerich FP, Shimada T, Oda Y (2000) Environ Mol Mutagen 36: 121-6 Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors. Shimada T, Murayama N, Okada K, Funae Y, Yamazaki H, Guengerich FP (2007) Chem Res Toxicol 20: 489-96 Structure-function relationships of inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2C9, and 3A4 by 33 flavonoid derivatives. Shimada T, Tanaka K, Takenaka S, Murayama N, Martin MV, Foroozesh MK, Yamazaki H, Guengerich FP, Komori M (2010) Chem Res Toxicol 23: 1921-35 Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2. Langouët S, Welti DH, Kerriguy N, Fay LB, Huynh-Ba T, Markovic J, Guengerich FP, Guillouzo A, Turesky RJ (2001) Chem Res Toxicol 14: 211-21 Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2. Turesky RJ, Parisod V, Huynh-Ba T, Langouët S, Guengerich FP (2001) Chem Res Toxicol 14: 901-11 Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. Turesky RJ, Constable A, Richoz J, Varga N, Markovic J, Martin MV, Guengerich FP (1998) Chem Res Toxicol 11: 925-36 Roles of cytochromes P450 1A2 and 3A4 in the oxidation of estradiol and estrone in human liver microsomes. Yamazaki H, Shaw PM, Guengerich FP, Shimada T (1998) Chem Res Toxicol 11: 659-65 Metabolic activation of aromatic amine mutagens by simultaneous expression of human cytochrome P450 1A2, NADPH-cytochrome P450 reductase, and N-acetyltransferase in Escherichia coli. Josephy PD, Evans DH, Parikh A, Guengerich FP (1998) Chem Res Toxicol 11: 70-4 Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons. Shimada T, Guengerich FP (2006) Chem Res Toxicol 19: 288-94 Inhibition of human cytochrome P450 enzymes by 1,2-dithiole-3-thione, oltipraz and its derivatives, and sulforaphane. Langouët S, Furge LL, Kerriguy N, Nakamura K, Guillouzo A, Guengerich FP (2000) Chem Res Toxicol 13: 245-52 Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds. Shimada T, Murayama N, Tanaka K, Takenaka S, Guengerich FP, Yamazaki H, Komori M (2011) Chem Res Toxicol 24: 1327-37
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.